Serum samples were collected at slaughter from 226 24-30-month-old American bison (Bison bison) bulls from Kansas, Minnesota, North Dakota, and Manitoba and assayed for antibodies to ovine herpesvirus type-2 (OHV-2), bovine viral diarrhea virus (BVDV), bovine herpesvirus type-1 (BHV-1), and bovine respiratory syncytial virus (BRSV). Antibodies were detected by serum neutralization for BVDV, BHV-1, and BRSV, while antibodies to OHV-2 were detected by competitive inhibition-ELISA (CI-ELISA). Detectable antibodies were found against all viruses: 10 of 226 (4.40%) against OHV-2, 125 of 226 (55.3%) against BVDV, 99 of 226 (43.8%) against BHV-1, and 208 of 226 (92.0%) against BRSV. Titers from 93.6% of the BVDVpositive animals, 79.8% of the BHV-1-positive animals, and 98.1% of the BRSV-positive animals were Ն1.25. These data indicate that a low percentage of clinically normal bison are seropositive for OHV-2 while a high percentage of bison sampled are seropositive for BVDV, BHV-1, and BRSV.
As the bison industry in North America continues to grow, health-related information on the species is needed to understand disease patterns related to production. The susceptibility of bison to the virus that causes malignant catarrhal fever (MCF), ovine herpesvirus type 2 (OHV-2), is well documented; however, there is a lack of data on the effect of major cattle viruses such as bovine herpesvirus type-1 (BHV-1), bovine viral diarrhea virus (BVDV), and bovine respiratory syncytial virus (BRSV) in this species. Malignant catarrhal fever virus, also known as OHV-2, causes a wide variety of clinical signs in bison ranging from sudden death to epithelial erosions, corneal opacity, and oculonasal discharge. 3, 5, 6, 9 Histopathologic changes are centered on the virus's ability to cause lymphocytic vasculitis, epithelial necrosis, and lymphoproliferation. 3, 5, 6 Serologic findings indicate that a low percentage of bison (0-9%) are seropositive to OHV-2 but are clinically normal. 4 Seroprevalence studies for BHV-1, BVDV, and parainfluenza (PI 3 ) have been done in European as well as American bison and indicate that variable numbers of animals seroconvert without obvious evidence of clinical disease. 7, 8 This study addresses the prevalence of antibody to OHV-2, BVDV, BHV-1, and BRSV in clinically normal, 2-year-old, ranch-raised bison bulls from Kansas, Minnesota, North Dakota, and Manitoba.
Blood samples were collected at slaughter from 226 24-30-month-old American bison (Bison bison) bulls. Samples were centrifuged and the serum was separated 12 hours after collection.
Bovine turbinate (BT) cells a were used in all serum neutralization assays. The BT cells were grown in Eagle minimum essential medium (MEM) b supplemented with 10% fetal bovine serum (FBS). b The cells were grown at 37 C in a humidified atmosphere of 5% CO 2 in air.
Bovine viral diarrhea virus (BVDV, Singer strain), bovine herpesvirus type-1 (BHV-1, Colorado strain), and bovine respiratory syncytial virus (BRSV, A51908-ATCCVR-794 strain) stocks were obtained from the North Dakota State University Veterinary Diagnostic Laboratory in Fargo, North Dakota.
Eight 5-fold dilutions of each serum sample were made in MEM, and 50 l of each dilution were added to 8 wells of a 96-well culture tray c,d,e (Eernisse K, NVSL Testing Protocol, Ames, IA). Diluted serum samples and virus (100-300 TCID 50 ) were mixed in duplicate wells and incubated at 37 C for 1 hour. Separate 96-well trays were used for each virus. The BT cells were added to all wells and the plates were incubated at 37 C with 5% CO 2 . Serum controls and virus back-titrations were performed with every assay. All wells were examined daily for cytopathic effects (CPE), and NA ‡ * Antibody titers that were Ն1:5 to BVDV, BHV-1, and BRSV were considered positive.
† Antibodies to OHV-2 (both SA-and WA-MCF) were detected by a competitive inhibition-enzyme-linked immunosorbent assay (CI-ELISA). 3 ‡ NA ϭ not applicable.
results were recorded on days 2, 5, and 7 for BHV-1, BVDV, and BRSV, respectively. The antibody titers were recorded as the highest dilution of serum where no CPE was observed. Antibody titers that were Ն1:5 to BVDV, BHV-1, and BRSV were considered positive. Antibodies to MCF (both SA-and WA-MCF) were detected by competitive inhibition-enzyme linked immunosorbent assay (CI-ELISA) performed by Dr. H. Li at Washington State University, Pullman, Washington. 2 Serum neutralizing antibody titers obtained using the bison serum are shown in Tables 1 and 2 . Table 1 shows the number of bison and the antibody titer against BVDV, BHV-1, and BRSV. Detectable antibodies were found against all 4 viruses: 10 of 226 (4.40%) to OHV-2, 125 of 226 (55.3%) to BVDV, 99 of 226 (43.8%) to BHV-1, and 208 of 226 (92%) to BRSV ( Table 2 ). Antibody titers in 93.6% of the BVDV positives, 79.8% of the BHV-1 positives, and 96.1% of the BRSV positives were Ն1:25 (Table 2).
Two hundred and twenty-six serum samples from 2-yearold, ranch-raised, clinically normal male bison were tested for antibodies to OHV-2, BVDV, BHV-1, and BRSV. Use of bovine vaccines in this group of bison is unknown. Use of such vaccines is presently inconsistent in the bison industry; therefore, it is likely that a significant percentage of these animals were not immunized. Descriptions of BVDV, BRSV, and BHV-1 infections in bison have not been reported, and the incidence of these diseases in bison is unknown. A report from Poland documented ulcerative balanoposthitis in a bull, but BHV-1 was not isolated. 1 Ranch-raised bison frequently have close contact with cattle, which may result in exposure to viruses and seroconversion. The current study would suggest that bison seroconvert when exposed to BVDV, BRSV, and BHV-1, but clinical disease is rare.
Conversely, only 4.4% of the serum samples demonstrated antibodies to OHV-2. This is a higher prevalence than a similar earlier study, which reported 2% seropositive bison (2/ 103) using the CI-ELISA technique. 2 It is unknown if the ranch-raised bison in this study were exposed to other species that could carry OHV-2. Serologic surveys of OHV-2 infection in bison are few but would indicate that a low percentage of clinically normal bison are seropositive for OHV-2. The implications of this finding are currently unknown. In consideration of the characteristic of herpesvirus infections to establish latency and to recrudesce, seropositive animals could be considered potential reservoirs of the virus. Whether or not seropositive, clinically normal bison would shed the virus when stressed is unknown. Since MCF can be such a devastating disease in bison, prepurchase testing of bison for antibodies to OHV-2 where appropriate might provide useful information to the producer. 
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